| Date | Time | Source | Headline | Symbol | Company |
| 08/23/2023 | 8:22PM | PR Newswire (Canada) | TSX Venture Exchange Stock Maintenance Bulletins | TSXV:RX | Biosyent Inc |
| 03/16/2021 | 7:01AM | PR Newswire (Canada) | Combogesic® - First Acetaminophen + Ibuprofen Combination Tablet - Now Available for Canadians with Acute Pain | TSXV:RX | Biosyent Inc |
| 03/16/2021 | 7:01AM | PR Newswire (Canada) | Combogesic(MD) - le premier comprimé associant l'acétaminophène et l'ibuprofène - maintenant disponible pour les Canadien... | TSXV:RX | Biosyent Inc |
| 05/25/2016 | 1:02PM | PR Newswire (Canada) | L'OCRCVM permet la reprise de la négociation - RX | TSXV:RX | Biosyent Inc |
| 05/25/2016 | 1:00PM | PR Newswire (Canada) | IIROC Trading Resumption - RX | TSXV:RX | Biosyent Inc |
| 05/25/2016 | 12:46PM | PR Newswire (Canada) | Suspension de la négociation par l'OCRCVM - RX | TSXV:RX | Biosyent Inc |
| 05/25/2016 | 12:44PM | PR Newswire (Canada) | IIROC Trading Halt - RX | TSXV:RX | Biosyent Inc |
| 07/23/2014 | 9:43AM | Marketwired Canada | BioSyent Pharma Signs Exclusive Licensing and Distribution Agreement For New Urgent Care Drug Product | TSXV:RX | Biosyent Inc |
| 07/11/2014 | 5:15PM | PR Newswire (Canada) | S&P Dow Jones Indices Announces Quarterly Review of S&P/TSX Venture Select Index | TSXV:RX | Biosyent Inc |
| 07/11/2014 | 5:15PM | PR Newswire (Canada) | Indices S&P Dow Jones annonce les résultats de l'analyse trimestrielle de l'indice sélect S&P/TSX de croissance | TSXV:RX | Biosyent Inc |
| 06/13/2014 | 5:12PM | Marketwired | BioSyent to Present at the 2014 Bloom Burton & Co. Healthcare Investor Conference | TSXV:RX | Biosyent Inc |
| 06/13/2014 | 5:12PM | Marketwired Canada | BioSyent to Present at the 2014 Bloom Burton & Co. Healthcare Investor Conference | TSXV:RX | Biosyent Inc |
| 06/12/2014 | 4:01PM | Marketwired | BioSyent Named to the PROFIT 500 Ranking of Canada's Fastest-Growing Companies with a 5 year Revenue Growth Rate of 608% | TSXV:RX | Biosyent Inc |
| 06/12/2014 | 4:01PM | Marketwired Canada | BioSyent Named to the PROFIT 500 Ranking of Canada's Fastest-Growing Companies with a 5 year Revenue Growth Rate of 608% | TSXV:RX | Biosyent Inc |
| 06/12/2014 | 8:00AM | Marketwired | BioSyent Pharma Receives Health Canada Approval to Market New Urgent Care Product | TSXV:RX | Biosyent Inc |
| 06/12/2014 | 8:00AM | Marketwired Canada | BioSyent Pharma Receives Health Canada Approval to Market New Urgent Care Product | TSXV:RX | Biosyent Inc |
| 06/06/2014 | 8:16AM | Marketwired | BioSyent Annual General Meeting of Shareholders - June 10, 2014 | TSXV:RX | Biosyent Inc |
| 06/06/2014 | 8:16AM | Marketwired Canada | BioSyent Annual General Meeting of Shareholders - June 10, 2014 | TSXV:RX | Biosyent Inc |
| 05/23/2014 | 8:00AM | Marketwired | BioSyent to Present at the 2014 Marcum MicroCap Investor Conference | TSXV:RX | Biosyent Inc |
| 05/23/2014 | 8:00AM | Marketwired Canada | BioSyent to Present at the 2014 Marcum MicroCap Investor Conference | TSXV:RX | Biosyent Inc |
| 05/21/2014 | 8:00AM | Marketwired | BioSyent Pharma Launches New RepaGyn® Hormone-Free Vaginal Suppositories | TSXV:RX | Biosyent Inc |
| 05/21/2014 | 8:00AM | Marketwired Canada | BioSyent Pharma Launches New RepaGyn® Hormone-Free Vaginal Suppositories | TSXV:RX | Biosyent Inc |
| 05/16/2014 | 8:00AM | Marketwired | BioSyent Releases First Quarter 2014 Results-Sales Increase 59%, Net Income After Tax Up 49% | TSXV:RX | Biosyent Inc |
| 05/16/2014 | 8:00AM | Marketwired Canada | BioSyent Releases First Quarter 2014 Results-Sales Increase 59%, Net Income After Tax Up 49% | TSXV:RX | Biosyent Inc |
| 03/12/2014 | 8:00AM | Marketwired Canada | BioSyent Releases Q4 and Full Year 2013 Results: Full Year Sales Increase 55%, Net Income Up 25%, 3 Year CAGR 67%, Q4 Sales I... | TSXV:RX | Biosyent Inc |
| 03/12/2014 | 8:00AM | Marketwired | BioSyent Releases Q4 & Full Year 2013 Results: Full Year Sales Increase 55%, Net Income Up 25%, 3 Year CAGR 67%, Q4 Sales Inc... | TSXV:RX | Biosyent Inc |
| 03/04/2014 | 8:00AM | Marketwired | BioSyent Pharma Signs Exclusive Licence & Distribution Agreement for a New Gastrointestinal Health Product Already Approved b... | TSXV:RX | Biosyent Inc |
| 03/04/2014 | 7:00AM | Marketwired Canada | BioSyent Pharma Signs Exclusive Licence and Distribution Agreement for a New Gastrointestinal Health Product Already Approved... | TSXV:RX | Biosyent Inc |
| 02/13/2014 | 8:00AM | Marketwired | BioSyent Named to the 2014 TSX Venture Top 50(R) Ranking-Only TSX Venture Company to Be Recognized as a Top Performer for the... | TSXV:RX | Biosyent Inc |
| 02/13/2014 | 7:00AM | Marketwired Canada | BioSyent Named to the 2014 TSX Venture Top 50(R) Ranking-Only TSX Venture Company to Be Recognized as a Top Performer for the... | TSXV:RX | Biosyent Inc |